← All trials
NCT04966559
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2021
- Primary completion
- Apr 30, 2023
- Completion date
- Apr 30, 2023
- First posted
- Jul 19, 2021
- Last posted
- Aug 16, 2021
- Enrollment
- 130
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Aalborg UniversityLead sponsor
- University of CopenhagenCollaborator
- Karolinska InstituteCollaborator
- University of Southern DenmarkCollaborator
- University of CopenhagenCollaborator
- Aalborg UniversitySponsor investigator
- Aalborg UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.